Learn more

MERZ PHARMA GMBH & CO KGAA

Overview
  • Total Patents
    1,449
  • GoodIP Patent Rank
    4,592
  • Filing trend
    ⇩ 66.0%
About

MERZ PHARMA GMBH & CO KGAA has a total of 1,449 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 1989. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are PALOMA PHARMACEUTICALS INC, MEDICAL THERAPIES LTD and SCHAPER & BRUEMMER GMBH.

Patent filings per year

Chart showing MERZ PHARMA GMBH & CO KGAAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kauss Valerjans 150
#2 Danysz Wojciech 140
#3 Henrich Markus 125
#4 Kalvinsh Ivars 110
#5 Hauptmeier Bernhard 102
#6 Jirgensons Aigars 87
#7 Eisele Karl-Heinz 86
#8 Althaus Michael 82
#9 Weil Tanja 82
#10 Parsons Christopher Graham Rap 63

Latest patents

Publication Filing date Title
WO2020169578A1 Novel uses of botulinum neurotoxin for the treatment of tremor
WO2020127407A1 Aldehyde-modified hyaluronic acid, method for preparing same and applications thereof
WO2020074419A1 Neurotoxin prefilled vial
WO2020070017A1 Novel uses of botulinum neurotoxin for treating lipoedema
CA3108125A1 Method for dynamic filtration of a cross-linked hydrogel
EP3763226A1 Composition for reducing hair loss and improving hair growth in cases of androgenetic alopecia
EP3813895A1 Fatty acid-grafted hyaluronic acid, dermal filler formulations comprising same, process for preparation and use thereof
EP3773768A1 Dermal filler based on crosslinked hyaluronic acid, calcium phosphate material particles and carboxymethyl cellulose, a process for preparing same and uses thereof
US2021008249A1 Porous biomaterials for tissue regeneration
EP3638345A1 Mixing nozzle, application device, kit and method using the mixing nozzle or application device
MX2019009860A Improved use of botulinum neurotoxin in the treatment of sialorrhea.
WO2019101308A1 Novel recombinant botulinum toxin with increased duration of effect
US2019269582A1 Method for preparing hyaluronic acid dermal fillers, dermal fillers obtained thereby and their use
US2021008156A1 Novel recombinant botulinum neurotoxins with increased duration of effect
WO2018077825A1 Treatment of gynoid lipodystrophy
WO2019007509A1 Novel recombinant botulinum neurotoxins with increased duration of effect
US2020048624A1 Novel recombinant botulinum toxin with increased duration of effect
WO2018228700A1 Finasteride for use in the treatment of androgenetic alopecia
TW201822826A Botulinum toxin prefilled syringe system, kit having the same and use thereof
WO2018206077A1 Emulsion comprising finasteride